(Q44835560)

English

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

scientific article published on 8 April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

author name string

P D Delmas

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R R Recker

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C H Chesnut

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A Skag

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J A Stakkestad

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R Emkey

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J Gilbride

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R C Schimmer

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C Christiansen

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

8 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Osteoporosis International

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

792-798

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-004-1602-9

0 references

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of osteoporosis and assessment of fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15071723

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-004-1602-9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44835560&oldid=2048875793"